Meetings To Implement Pandemic Response Voluntary Agreement Under Section 708 of the Defense Production Act, 30063-30064 [2021-11786]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 106 / Friday, June 4, 2021 / Notices
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Advisory Board and NCI Board of Scientific
Advisors.
Date: June 14, 2021.
Open: 11:00 a.m. to 12:00 p.m.
Agenda: NCAB Subcommittee Meetings—
Subcommittee on Planning and Budget.
Open: 12:05 p.m. to 4:00 p.m.
Agenda: Joint meeting of the National
Cancer Advisory Board and NCI Board of
Scientific Advisors, NCI Director’s report and
presentations.
Closed: 4:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute—Shady
Grove, 9609 Medical Center Drive, Rockville,
MD 20850 (Virtual Meeting).
Name of Committee: National Cancer
Advisory Board and NCI Board of Scientific
Advisors.
Date: June 15, 2021.
Open: 1:00 p.m. to 3:00 p.m.
Agenda: Joint meeting of the National
Cancer Advisory Board and NCI Board of
Scientific Advisors, NCI Board of Scientific
Advisors Concepts Review, Ongoing and
New Business.
Place: National Cancer Institute—Shady
Grove, 9609 Medical Center Drive, Rockville,
MD 20850 (Virtual Meeting).
Contact Person: Paulette S. Gray, Ph.D.
Director, Division of Extramural Activities,
National Cancer Institute—Shady Grove,
National Institutes of Health, 9609 Medical
Center Drive, 7th Floor, Room. 7W444,
Bethesda, MD 20892, 240–276–6340, grayp@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
NCAB: https://deainfo.nci.nih.gov/
advisory/ncab/ncabmeetings.htm,
BSA: https://deainfo.nci.nih.gov/advisory/
bsa/bsameetings.htm, where an agenda and
any additional information for the meeting
will be posted when available.
This notice is being published less than 15
days prior to the meeting due to scheduling
difficulties.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
VerDate Sep<11>2014
17:08 Jun 03, 2021
Jkt 253001
Dated: June 1, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–11783 Filed 6–3–21; 8:45 am]
30063
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
BILLING CODE 4140–01–P
[Docket ID FEMA–2020–0016]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meetings To Implement Pandemic
Response Voluntary Agreement Under
Section 708 of the Defense Production
Act
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, National Cancer Institute.
The meeting will be closed to the public
as indicated below in accordance with
the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Cancer Institute, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, National Cancer Institute.
Date: July 12–13, 2021.
Time: 11:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Cancer Institute—Shady
Grove, 9609 Medical Center Drive, Rockville,
MD 20850 (Virtual Meeting).
Contact Person: Brian E. Wojcik, Ph.D.,
Senior Review Administrator, Institute
Review Office, Office of the Director,
National Cancer Institute, National Institutes
of Health, 9609 Medical Center Drive, Room
3W414, Rockville, MD 20850, 240–276–5660,
wojcikb@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: June 1, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–11784 Filed 6–3–21; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: Announcement of meetings.
AGENCY:
The Federal Emergency
Management Agency (FEMA) held two
meetings to implement the Voluntary
Agreement for the Manufacture and
Distribution of Critical Healthcare
Resources Necessary to Respond to a
Pandemic.
DATES: The first meeting took place on
Tuesday, May 25, 2021, from 10:30 a.m.
to 12 p.m. Eastern Time (ET). The
second meeting took place on
Wednesday, May 26, 2021, from 2 to 3
p.m. ET.
FOR FURTHER INFORMATION CONTACT:
Robert Glenn, Office of Business,
Industry, Infrastructure Integration, via
email at OB3I@fema.dhs.gov or via
phone at (202) 212–1666.
SUPPLEMENTARY INFORMATION: Notice of
these meetings is provided as required
by section 708(h)(8) of the Defense
Production Act (DPA), 50 U.S.C.
4558(h)(8), and consistent with 44 CFR
part 332.
The DPA authorizes the making of
‘‘voluntary agreements and plans of
action’’ with representatives of industry,
business, and other interests to help
provide for the national defense.1 The
President’s authority to facilitate
voluntary agreements with respect to
responding to the spread of COVID–19
within the United States was delegated
to the Secretary of Homeland Security
in Executive Order 13911.2 The
Secretary of Homeland Security further
delegated this authority to the FEMA
Administrator.3
On August 17, 2020, after the
appropriate consultations with the
Attorney General and the Chairman of
the Federal Trade Commission, FEMA
completed and published in the Federal
Register a ‘‘Voluntary Agreement,
Manufacture and Distribution of Critical
Healthcare Resources Necessary to
SUMMARY:
1 50
U.S.C. 4558(c)(1).
FR 18403 (Apr. 1, 2020).
3 DHS Delegation 09052, Rev. 00.1 (Apr. 1, 2020);
DHS Delegation Number 09052 Rev. 00 (Jan. 3,
2017).
2 85
E:\FR\FM\04JNN1.SGM
04JNN1
30064
Federal Register / Vol. 86, No. 106 / Friday, June 4, 2021 / Notices
Respond to a Pandemic’’ (Voluntary
Agreement).4 Unless terminated earlier,
the Voluntary Agreement is effective
until August 17, 2025, and may be
extended subject to additional approval
by the Attorney General after
consultation with the Chairman of the
Federal Trade Commission. The
Agreement may be used to prepare for
or respond to any pandemic, including
COVID–19, during that time.
On December 7, 2020, the first plan of
action under the Voluntary
Agreement—the Plan of Action to
Establish a National Strategy for the
Manufacture, Allocation, and
Distribution of Personal Protective
Equipment (PPE) to Respond to COVID–
19 (Plan of Action)—was finalized.5 The
Plan of Action established several subcommittees under the Voluntary
Agreement, focusing on different
aspects of the Plan of Action.
The meetings were chaired by the
FEMA Administrator or her delegate
and attended by the Attorney General
and the Chairman of the Federal Trade
Commission or their delegates. In
implementing the Voluntary Agreement,
FEMA adheres to all procedural
requirements of 50 U.S.C. 4558 and 44
CFR part 332.
Meeting Objectives: The objectives of
the meetings were as follows:
1. Gather committee Participants and
Attendees to ask targeted questions for
situational awareness about PPE, drug
products and drug substances,
diagnostic test kits, medical devices,
and medical gases.
2. Establish priorities for COVID–19
response under the Voluntary
Agreement.
3. Identify tasks that should be
completed under the appropriate SubCommittee.
4. Identify information gaps and areas
that merit sharing (both from FEMA to
the private sector and vice versa).
Meetings Closed to the Public: By
default, the DPA requires meetings held
to implement a voluntary agreement or
plan of action be open to the public.6
However, attendance may be limited if
the Sponsor 7 of the voluntary
4 85 FR 50035 (Aug. 17, 2020). The Attorney
General, in consultation with the Chairman of the
Federal Trade Commission, made the required
finding that the purpose of the voluntary agreement
may not reasonably be achieved through an
agreement having less anticompetitive effects or
without any voluntary agreement and published the
finding in the Federal Register on the same day. 85
FR 50049 (Aug. 17, 2020).
5 See 85 FR 78869 (Dec. 7, 2020). See also 85 FR
79020 (Dec. 8, 2020).
6 See 50 U.S.C. 4558(h)(7).
7 ‘‘[T]he individual designated by the President in
subsection (c)(2) [of section 708 of the DPA] to
administer the voluntary agreement, or plan of
action.’’ 50 U.S.C. 4558(h)(7).
VerDate Sep<11>2014
17:08 Jun 03, 2021
Jkt 253001
agreement finds that the matter to be
discussed at a meeting falls within the
purview of matters described in 5 U.S.C.
552b(c), such as trade secrets and
commercial or financial information.
The Sponsor of the Voluntary
Agreement, the FEMA Administrator,
found that these meetings to implement
the Voluntary Agreement involved
matters which fall within the purview of
matters described in 5 U.S.C. 552b(c)
and the meetings were therefore closed
to the public.
Specifically, these meetings to
implement the Voluntary Agreement
may have required participants to
disclose trade secrets or commercial or
financial information that is privileged
or confidential. Disclosure of such
information allows for meetings to be
closed pursuant to 5 U.S.C. 552b(c)(4).
In addition, the success of the Voluntary
Agreement depends wholly on the
willing and enthusiastic participation of
private sector participants. Failure to
close these meetings could have had a
strong chilling effect on private sector
participation and caused a substantial
risk that sensitive information would be
prematurely released to the public,
leading to participants withdrawing
their support from the Voluntary
Agreement. This would have
significantly frustrated the
implementation of the Voluntary
Agreement. Frustration of an agency’s
objective due to premature disclosure of
information allows for the closure of a
meeting pursuant to 5 U.S.C.
552b(c)(9)(B).
Deanne Criswell,
Administrator, Federal Emergency
Management Agency.
[FR Doc. 2021–11786 Filed 6–3–21; 8:45 am]
BILLING CODE 9111–19–P
DEPARTMENT OF HOMELAND
SECURITY
Transportation Security Administration
Intent To Request a Revision From
OMB of One Current Public Collection
of Information: Department of
Homeland Security Traveler Redress
Inquiry Program (DHS TRIP)
Transportation Security
Administration, Homeland Security
(DHS).
ACTION: 60-Day notice.
AGENCY:
The Transportation Security
Administration (TSA) invites public
comment on one currently approved
Information Collection Request (ICR),
Office of Management and Budget
(OMB) control number 1652–0044,
SUMMARY:
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
abstracted below that we will submit to
OMB for a revision in compliance with
the Paperwork Reduction Act (PRA).
The ICR describes the nature of the
information collection and its expected
burden. The collection involves the
submission of identifying the travel
experience information submitted by
individuals requesting redress through
the Department of Homeland Security
(DHS) Traveler Redress Inquiry Program
(TRIP).
DATES: Send your comments by August
3, 2021.
ADDRESSES: Comments may be emailed
to TSAPRA@tsa.dhs.gov or delivered to
the TSA PRA Officer, Information
Technology, TSA–11, Transportation
Security Administration, 6595
Springfield Center Drive, Springfield,
VA 20598–6011.
FOR FURTHER INFORMATION CONTACT:
Christina A. Walsh at the above address,
or by telephone (571) 227–2062.
SUPPLEMENTARY INFORMATION:
Comments Invited
In accordance with the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501
et seq.), an agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a valid OMB control
number. The ICR documentation will be
available at https://www.reginfo.gov
upon its submission to OMB. Therefore,
in preparation for OMB review and
approval of the following information
collection, TSA is soliciting comments
to—
(1) Evaluate whether the proposed
information requirement is necessary for
the proper performance of the functions
of the agency, including whether the
information will have practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including using
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Information Collection Requirement
OMB Control Number 1652–0044;
Department of Homeland Security
Traveler Redress Inquiry Program (DHS
TRIP). DHS TRIP is a single point of
contact for individuals who have
inquiries or seek resolution regarding
difficulties they have experienced
during their travel screening. These
difficulties could include: (1) Denied or
E:\FR\FM\04JNN1.SGM
04JNN1
]]>Agencies
[Federal Register Volume 86, Number 106 (Friday, June 4, 2021)]
[Notices]
[Pages 30063-30064]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11786]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HOMELAND SECURITY
Federal Emergency Management Agency
[Docket ID FEMA-2020-0016]
Meetings To Implement Pandemic Response Voluntary Agreement Under
Section 708 of the Defense Production Act
AGENCY: Federal Emergency Management Agency, Department of Homeland
Security.
ACTION: Announcement of meetings.
-----------------------------------------------------------------------
SUMMARY: The Federal Emergency Management Agency (FEMA) held two
meetings to implement the Voluntary Agreement for the Manufacture and
Distribution of Critical Healthcare Resources Necessary to Respond to a
Pandemic.
DATES: The first meeting took place on Tuesday, May 25, 2021, from
10:30 a.m. to 12 p.m. Eastern Time (ET). The second meeting took place
on Wednesday, May 26, 2021, from 2 to 3 p.m. ET.
FOR FURTHER INFORMATION CONTACT: Robert Glenn, Office of Business,
Industry, Infrastructure Integration, via email at [email protected] or
via phone at (202) 212-1666.
SUPPLEMENTARY INFORMATION: Notice of these meetings is provided as
required by section 708(h)(8) of the Defense Production Act (DPA), 50
U.S.C. 4558(h)(8), and consistent with 44 CFR part 332.
The DPA authorizes the making of ``voluntary agreements and plans
of action'' with representatives of industry, business, and other
interests to help provide for the national defense.\1\ The President's
authority to facilitate voluntary agreements with respect to responding
to the spread of COVID-19 within the United States was delegated to the
Secretary of Homeland Security in Executive Order 13911.\2\ The
Secretary of Homeland Security further delegated this authority to the
FEMA Administrator.\3\
---------------------------------------------------------------------------
\1\ 50 U.S.C. 4558(c)(1).
\2\ 85 FR 18403 (Apr. 1, 2020).
\3\ DHS Delegation 09052, Rev. 00.1 (Apr. 1, 2020); DHS
Delegation Number 09052 Rev. 00 (Jan. 3, 2017).
---------------------------------------------------------------------------
On August 17, 2020, after the appropriate consultations with the
Attorney General and the Chairman of the Federal Trade Commission, FEMA
completed and published in the Federal Register a ``Voluntary
Agreement, Manufacture and Distribution of Critical Healthcare
Resources Necessary to
[[Page 30064]]
Respond to a Pandemic'' (Voluntary Agreement).\4\ Unless terminated
earlier, the Voluntary Agreement is effective until August 17, 2025,
and may be extended subject to additional approval by the Attorney
General after consultation with the Chairman of the Federal Trade
Commission. The Agreement may be used to prepare for or respond to any
pandemic, including COVID-19, during that time.
---------------------------------------------------------------------------
\4\ 85 FR 50035 (Aug. 17, 2020). The Attorney General, in
consultation with the Chairman of the Federal Trade Commission, made
the required finding that the purpose of the voluntary agreement may
not reasonably be achieved through an agreement having less
anticompetitive effects or without any voluntary agreement and
published the finding in the Federal Register on the same day. 85 FR
50049 (Aug. 17, 2020).
---------------------------------------------------------------------------
On December 7, 2020, the first plan of action under the Voluntary
Agreement--the Plan of Action to Establish a National Strategy for the
Manufacture, Allocation, and Distribution of Personal Protective
Equipment (PPE) to Respond to COVID-19 (Plan of Action)--was
finalized.\5\ The Plan of Action established several sub-committees
under the Voluntary Agreement, focusing on different aspects of the
Plan of Action.
---------------------------------------------------------------------------
\5\ See 85 FR 78869 (Dec. 7, 2020). See also 85 FR 79020 (Dec.
8, 2020).
---------------------------------------------------------------------------
The meetings were chaired by the FEMA Administrator or her delegate
and attended by the Attorney General and the Chairman of the Federal
Trade Commission or their delegates. In implementing the Voluntary
Agreement, FEMA adheres to all procedural requirements of 50 U.S.C.
4558 and 44 CFR part 332.
Meeting Objectives: The objectives of the meetings were as follows:
1. Gather committee Participants and Attendees to ask targeted
questions for situational awareness about PPE, drug products and drug
substances, diagnostic test kits, medical devices, and medical gases.
2. Establish priorities for COVID-19 response under the Voluntary
Agreement.
3. Identify tasks that should be completed under the appropriate
Sub-Committee.
4. Identify information gaps and areas that merit sharing (both
from FEMA to the private sector and vice versa).
Meetings Closed to the Public: By default, the DPA requires
meetings held to implement a voluntary agreement or plan of action be
open to the public.\6\ However, attendance may be limited if the
Sponsor \7\ of the voluntary agreement finds that the matter to be
discussed at a meeting falls within the purview of matters described in
5 U.S.C. 552b(c), such as trade secrets and commercial or financial
information. The Sponsor of the Voluntary Agreement, the FEMA
Administrator, found that these meetings to implement the Voluntary
Agreement involved matters which fall within the purview of matters
described in 5 U.S.C. 552b(c) and the meetings were therefore closed to
the public.
---------------------------------------------------------------------------
\6\ See 50 U.S.C. 4558(h)(7).
\7\ ``[T]he individual designated by the President in subsection
(c)(2) [of section 708 of the DPA] to administer the voluntary
agreement, or plan of action.'' 50 U.S.C. 4558(h)(7).
---------------------------------------------------------------------------
Specifically, these meetings to implement the Voluntary Agreement
may have required participants to disclose trade secrets or commercial
or financial information that is privileged or confidential. Disclosure
of such information allows for meetings to be closed pursuant to 5
U.S.C. 552b(c)(4). In addition, the success of the Voluntary Agreement
depends wholly on the willing and enthusiastic participation of private
sector participants. Failure to close these meetings could have had a
strong chilling effect on private sector participation and caused a
substantial risk that sensitive information would be prematurely
released to the public, leading to participants withdrawing their
support from the Voluntary Agreement. This would have significantly
frustrated the implementation of the Voluntary Agreement. Frustration
of an agency's objective due to premature disclosure of information
allows for the closure of a meeting pursuant to 5 U.S.C. 552b(c)(9)(B).
Deanne Criswell,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2021-11786 Filed 6-3-21; 8:45 am]
BILLING CODE 9111-19-P
